Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
25 sept. 2024 16h05 HE
|
Telesis Bio
SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient...
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
10 sept. 2024 16h30 HE
|
Telesis Bio
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic...
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
07 août 2024 16h05 HE
|
Telesis Bio
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
Telesis Bio Reports First Quarter 2024 Financial Results
09 mai 2024 16h05 HE
|
Telesis Bio
Telesis Bio Reports First Quarter 2024 Financial Results
Telesis Bio Announces Reverse Stock Split
06 mai 2024 16h05 HE
|
Telesis Bio
Telesis Bio Announces Reverse Stock Split
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
18 avr. 2024 09h00 HE
|
Telesis Bio
Telesis Bio Inc. announces strategic focus on mRNA solutions and announces new leadership
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
28 mars 2024 16h05 HE
|
Telesis Bio
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
26 févr. 2024 09h15 HE
|
Telesis Bio
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Telesis Bio Reports Third Quarter 2023 Financial Results
13 nov. 2023 16h22 HE
|
Telesis Bio
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter...
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
07 nov. 2023 09h00 HE
|
Telesis Bio
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023...